Lamivudine Tablet, Film Coated
Product Images NDC 64380-710

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 64380-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 01

FDA Label Image

E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 02

E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 02
The text appears to be a combination of some numbers, alphabets, symbols and a medical prescription for the drug "Lamivudine" with a recommended dosage of 300 mg once daily. There is also a graph that seems to display treatment time in weeks. No further information is available to provide a more detailed description.*
FDA Label Image

E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 03

FDA Label Image

E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 04

E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 04
This is a label for medication, specifically for Chlorzoxazone tablets (brand name: Lorzone). The label includes information about how to store the medication and contact information for the distributor, Strides Pharma Inc. The medication is designed to treat muscle spasms and is available by prescription only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.